Table 1.
Bioactive Component |
Author (Year) |
Species (n) |
Milk Collection Standardized |
Lactation Time Point(s) |
Maternal Influence | Infant Outcomes | Weakness/Limitations |
---|---|---|---|---|---|---|---|
miRNA | Xi (2016) | Human (n=86) | No | 2-5d, 3 mo | miRNA-30B, let-7a, miRNA-378 in colostrum & mature milk are negatively correlated with maternal BMI (pre-pregnancy & late pregnancy), weight Let-7a in mature milk is negative correlated with late pregnancy maternal weight No miRNA differences with gestational diabetes mellitus or gestational age. |
miRNA-30B & miRNA-378 were higher in colostrum for girls | No maternal diet data No infant anthropometrics |
Zamanillo (2019) | Human (n=59) | Yes | 1mo, 2mo, 3mo | NW mothers had negative correlations between milk miRNAs expression Leptin/adiponectin levels observed in NW but not in OW/OB mothers |
In NW mothers, infant BMI at 2 years negatively correlated with miRNA at 2m (miR-103, miR-17, miR-181a, miR-222, miR-let7c, miR-146b). No infant growth correlations with OW/OB mothers |
No maternal diet data Infant growth at 2 years & maternal BMI were obtained by maternal recall |
|
Shah (2021) | Human (n=60) | Yes | 1mo & 3mo | Decreased miRNA (miR-148a, miR-30b) abundance at 1mo in OW/OB mothers compared to NW mothers | miR-184a was negatively associated with infant weight, FM and FFM at 1m miR-32 was negatively associated with 1m infant weight miR-30b abundance was positively associated with 1m weight, %fat & fat mass. No significant associations were observed with 1m milk miRNA & 6m infant anthropometrics, or between 3m milk miRNA and infant anthropometrics at 3m or 6m |
No maternal diet data | |
Lipokines&Signaling lipids | Brezinova (2018) | Human (n=53) & Mouse | No | 72 hr | PAHSAs levels were positively associated with weight gain in pregnancy. Obese mothers had lower total PAHSA and 5-PAHSA levels |
No outcomes examined | No maternal diet data. No infant outcomes examined |
Bruun (2018) | Human (n=100) | No | 4mo | Only adjusted for maternal BMI | The low weight z-score group had higher concentrations of oleoylethanolamide, steroylethanolamide, palitoylethanolamide vs infants in the high weight z-score. Lower skinfold thickness & weight gain per day were associated with higher milk steroylethanolamide |
No early lactation samples. No maternal diet data. Storage techniques altered concentration of N-acylethanolamides. |
|
Wolfs (2021) | Human (n=58) | Yes | 1mo, 3mo, 6mo | 12,13-diHOME positively associated with height, however no association with maternal pre-pregnancy BMI or gestational weight gain 12,13-diHOME concentration increased in milk after exercise at 1mo postpartum |
12,13-diHOME was positively associated with birth weight for length and BMI z-score, and negatively associated with in BMI & weight for length z-score over the first 6 months of life 12,13-diHOME was negatively associated with subcutaneous and overall adiposity at 1mo No association between infant sex and milk 12,13-diHOME levels High milk succinate was associated with lower infant BMI at 6mo |
No maternal diet data. | |
Small molecules & Metabolites | Isganaitis (2019) | Human (n=35) | Yes | 1mo, 6mo | Maternal BMI was associated with 10 differing metabolites at 1mo 20 differing metabolites at 6mo 1mo, maternal obesity was linked to differences in human milk orotate & 1,5-anhydroglucitol 6mo maternal obesity was associated with increased acylcarnitine, monosaccharide, & 1,5-anhydroglucitol |
Adenine positively correlated with infant weight at 1mo, while X-19656 (an unidentified metabolite) was negative correlated 1mo, 5-methylthioadenosine was positively correlated with infant %fat and maternal BMI. No correlations between milk metabolites with infant weight or adiposity and maternal BMI at 6mo |
No maternal diet data. |
Prentice (2019) | Human (n=619) | Yes | 4-8wks | SCFAs were not associated with maternal BMI Mothers exclusively breastfeeding had higher milk butyrate |
Butyrate was negatively associated with infant weight between 3mo-12mo Milk formic acid levels were negative associated with BMI over the first 2 years of life Acetate was negatively associated with skinfold thickness at 3mo |
No maternal diet data. | |
Saben (2020) | Human (n=159) | Yes | 2wk, 2mo, 6mo | Maternal BMI & %fat positively correlated with amount of human milk monosaccharides & sugar alcohols | 6mo milk mannose, lyxitol & shikimic acid showed a positive association with infant fat mass & %fat | No maternal diet data. | |
Ribo (2021) | Human (n=143) & Mouse | Yes | 1mo | Did not report maternal influence on milk betaine | Human milk betaine concentration was inversely associated with infant weight-for-length z-score at 1mo & 12mo | No maternal diet data | |
In mice supplemented with betaine, a fivefold increase in betaine milk content was observed | In mice, early-exposure to betaine in lactation was associated with decreased adiposity & improved glucose homeostasis in adult mice. Betaine intake transiently increases offspring Akkermansia species during early life, which is linked to lower gut inflammation in mice |
||||||
Fructose | Goran (2017) | Human (n=25) | Yes | 1mo, 6mo | Maternal BMI was used as a covariate | Milk fructose was associated with high infant body weight, lean mass, FM, weight for length z-score, & bone mineral content at 6mo | No maternal diet data. |
Berger (2018) | Human (n=41) | Yes | 6 wks | HFCS-sweetened beverage increased milk fructose for up to 5 hrs without an impact on milk glucose or lactose. | None were collected | No infant outcomes No maternal diet data |
|
Berger (2020) | Human (n=88) | NA | NA | No differences in maternal fructose or sugar-sweetened beverage + juice intake based on maternal pre-pregnancy BMI | Infant 24mo cognitive development scores were inversely correlated with fructose consumption by their mothers at 1mo postpartum No association at 6mo postpartum |
Homogenous sample (limited to Hispanic mother-infant dyads) No milk compositional analysis was performed |